Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Current Taxes: 2014-2020

Historic Current Taxes for Myriad Genetics (MYGN) over the last 5 years, with Jun 2020 value amounting to $6.1 million.

  • Myriad Genetics' Current Taxes rose 103.33% to $6.1 million in Q2 2020 from the same period last year, while for Jun 2020 it was $6.1 million, marking a year-over-year increase of 103.33%. This contributed to the annual value of $6.1 million for FY2020, which is 103.33% up from last year.
  • As of Q2 2020, Myriad Genetics' Current Taxes stood at $6.1 million, which was up 74.29% from $3.5 million recorded in Q1 2020.
  • In the past 5 years, Myriad Genetics' Current Taxes registered a high of $9.8 million during Q3 2018, and its lowest value of $2.3 million during Q1 2016.
  • Moreover, its 3-year median value for Current Taxes was $4.2 million (2018), whereas its average is $5.0 million.
  • In the last 5 years, Myriad Genetics' Current Taxes surged by 168.75% in 2017 and then tumbled by 39.44% in 2018.
  • Over the past 5 years, Myriad Genetics' Current Taxes (Quarterly) stood at $3.0 million in 2016, then climbed by 6.67% to $3.2 million in 2017, then soared by 53.12% to $4.9 million in 2018, then fell by 18.37% to $4.0 million in 2019, then soared by 103.33% to $6.1 million in 2020.
  • Its last three reported values are $6.1 million in Q2 2020, $3.5 million for Q1 2020, and $4.0 million during Q4 2019.